Tango rises after Q4 results, clinical pact with Erasca
Source: SeekingAlpha
2026-03-05 13:46:18 ET
More on Tango Therapeutics, Erasca
- Tango Therapeutics, Inc. (TNGX) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- Tango Therapeutics, Inc. (TNGX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Erasca, Inc. (ERAS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Erasca prices $225M stock offering at $10 per share
- Seeking Alpha’s Quant Rating on Tango Therapeutics
Read the full article on Seeking Alpha
For further details see:
Tango rises after Q4 results, clinical pact with Erasca
Tango Therapeutics Inc.
NASDAQ: TNGX
TNGX Trading
-1.98% G/L:
$16.56 Last:
820,139 Volume:
$16.39 Open:
TNGX Latest News
March 06, 2026 05:33:52 pm
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
TNGX Stock Data
$1,709,052,323
80,160,147
2.71%
43
N/A
Biotechnology & Life Sciences
Healthcare
US
Boston
